Literature DB >> 26661897

Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.

Francesca M Notarangelo1, Xiao-Dan Wang1, Kyle J Horning1, Robert Schwarcz1.   

Abstract

The kynurenine pathway (KP), the major catabolic route of the essential amino acid l-tryptophan (l-TRP), contains several neuroactive compounds, including kynurenic acid, 3-hydroxykynurenine (3-HK), and quinolinic acid (QUIN). The role of the d-enantiomer (d-TRP) in KP metabolism has received little attention so far. d-TRP can be converted to l-TRP by d-amino acid oxidase, and the same enzyme can produce d-kynurenine, a known bioprecursor of KYNA. To analyze these complex metabolic events systematically in vivo, we injected mice with d-TRP (300 mg/kg, i.p.) and examined KP metabolism in the absence or presence of the d-amino acid oxidase inhibitor 3-methylpyrazole-5-carboxylic acid (MPC; 100 mg/kg, i.p.,). After 90 min, newly formed l-TRP was recovered in plasma, liver, forebrain, and cerebellum, and MPC prevented its neosynthesis in all tissues. In the same animals, de novo production of d-kynurenine from d-TRP was also observed, but was much higher in the periphery than in the brain. d-TRP administration raised KYNA, 3-HK, and QUIN levels in all tissues examined, and KYNA production from d-TRP was significantly reduced after pre-treatment with MPC. These results indicate that catabolic routes other than those classically ascribed to l-TRP and l-kynurenine can account for the synthesis of KYNA, 3-HK and QUINin vivo. The essential amino acid l-tryptophan is catabolized via the kynurenine pathway (KP). We explored the role of the d-enantiomer in KP metabolism in mice in vivo. We report that d-tryptophan is metabolized in both brain and periphery and converted to KP metabolites, including d-kynurenine and l-kynurenine, kynurenic acid, 3-hydroxykynurenine, and quinolinic acid. Pharmacological experiments confirm the involvement of d-amino acid oxidase in these processes. Our results indicate that this enzyme participates in the synthesis of KP metabolites from d-tryptophan.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  3-hydroxykynurenine; kynurenic acid; quinolinic acid

Year:  2016        PMID: 26661897      PMCID: PMC4902784          DOI: 10.1111/jnc.13455

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  66 in total

1.  D-amino-acid oxidase is not present in the mouse liver.

Authors:  R Konno; M Sasaki; S Asakura; K Fukui; J Enami; A Niwa
Journal:  Biochim Biophys Acta       Date:  1997-04-17

2.  Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.

Authors:  Kana Ishii; Tadahiro Ogaya; Ziyu Song; Hideaki Iizuka; Takeshi Fukushima
Journal:  Chirality       Date:  2010-11       Impact factor: 2.437

Review 3.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

Review 4.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

5.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Contryphan is a D-tryptophan-containing Conus peptide.

Authors:  E C Jimenéz; B M Olivera; W R Gray; L J Cruz
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

Review 7.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

8.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

9.  Alternative kynurenic acid synthesis routes studied in the rat cerebellum.

Authors:  Tonali Blanco Ayala; Rafael Lugo Huitrón; Liliana Carmona Aparicio; Daniela Ramírez Ortega; Dinora González Esquivel; José Pedraza Chaverrí; Gonzalo Pérez de la Cruz; Camilo Ríos; Robert Schwarcz; Verónica Pérez de la Cruz
Journal:  Front Cell Neurosci       Date:  2015-05-18       Impact factor: 5.505

10.  D-amino acids govern stationary phase cell wall remodeling in bacteria.

Authors:  Hubert Lam; Dong-Chan Oh; Felipe Cava; Constantin N Takacs; Jon Clardy; Miguel A de Pedro; Matthew K Waldor
Journal:  Science       Date:  2009-09-18       Impact factor: 47.728

View more
  8 in total

1.  Promoting epithelial-to-mesenchymal transition by D-kynurenine via activating aryl hydrocarbon receptor.

Authors:  Zhiqing Duan; Yan Li; Lu Li
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

2.  Quantification of IDO1 enzyme activity in normal and malignant tissues.

Authors:  Lijie Zhai; Erik Ladomersky; April Bell; Corey Dussold; Krislyn Cardoza; Jun Qian; Kristen L Lauing; Derek A Wainwright
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

Review 3.  Mouse d-Amino-Acid Oxidase: Distribution and Physiological Substrates.

Authors:  Reiko Koga; Yurika Miyoshi; Hiroaki Sakaue; Kenji Hamase; Ryuichi Konno
Journal:  Front Mol Biosci       Date:  2017-12-04

Review 4.  Chromatographic analysis of tryptophan metabolites.

Authors:  Ilona Sadok; Andrzej Gamian; Magdalena Maria Staniszewska
Journal:  J Sep Sci       Date:  2017-06-26       Impact factor: 3.645

Review 5.  Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.

Authors:  L A Ramos-Chávez; R Lugo Huitrón; D González Esquivel; B Pineda; C Ríos; D Silva-Adaya; L Sánchez-Chapul; G Roldán-Roldán; V Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2018-05-24       Impact factor: 6.543

Review 6.  Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism.

Authors:  Masaru Tanaka; Zsuzsanna Bohár; László Vécsei
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

Review 7.  Advances in D-Amino Acids in Neurological Research.

Authors:  James M Seckler; Stephen J Lewis
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

8.  Mining for Active Molecules in Probiotic Supernatant by Combining Non-Targeted Metabolomics and Immunoregulation Testing.

Authors:  Juliano Roldan Fonseca; Marianna Lucio; Mourad Harir; Philippe Schmitt-Kopplin
Journal:  Metabolites       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.